The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification

Area of Science:

• Molecular biology
• Genetics
• Biochemistry

Background:

• Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by progressive heterotopic ossification (HO) due to ACVR1 gene mutations.
• Mutant ACVR1 exhibits constitutive activation and hypersensitivity to bone morphogenetic protein (BMP) signaling, contributing to HO.
• HO is a complex process involving multiple signaling pathways, including hypoxia-inducible factor (HIF) and mechanistic target of rapamycin (mTOR).

Approach:

• This review synthesizes recent research on the roles of HIF-1α and mTOR pathways in amplifying HO lesions.
• It examines how these pathways interact with BMP signaling in both genetic (FOP) and acquired forms of HO.
• The review discusses potential therapeutic strategies targeting HIF-1α and mTOR for clinical intervention.

Key Points:

• HIF-1α and mTOR pathways are crucial in mediating both genetic and acquired HO.
• Inhibition of HIF-1α or mTOR can reduce HO formation in preclinical models, partly by dampening BMP pathway signaling.
• Understanding the interplay between HIF-1α, mTOR, and BMP signaling is key to developing new treatments for HO.

Conclusions:

• HIF and mTOR pathways represent promising therapeutic targets for FOP and other forms of HO.
• Targeting these pathways may offer novel clinical interventions to manage irreversible mobility loss caused by heterotopic ossification.